| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
300,672,000 |
| Market
Cap: |
441.99(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.36 - $14.05 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 7.8 |
| Insider 6 Months : 7.8 |
| Insider 3/6 Months : 16 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pacific Biosciences of California is a life science technology company that is designing, developing and manufacturing sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Co.'s products address solutions across a set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Co. has developed HiFi long-read sequencing combined with Single Molecule Real-Time technology, which enables single-molecule, real-time detection of nucleic acid sequences for long-read applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
40,000 |
40,000 |
40,000 |
40,000 |
| Total Buy Value |
$176,160 |
$176,160 |
$176,160 |
$176,160 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
192,570 |
243,582 |
436,886 |
654,669 |
| Total Sell Value |
$1,111,017 |
$1,552,073 |
$3,531,312 |
$5,254,296 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
11 |
13 |
20 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hunkapiller Michael |
Director |
– • – |
2021-01-20 |
4 |
OE |
$2.27 |
$488,109 |
D/D |
215,026 |
1,113,241 |
|
- |
|
| Fromen Peter |
Chief Commercial Officer |
• – – |
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
160,000 |
160,000 |
|
- |
|
| Van Oene Mark |
Chief Operating Officer |
• – – |
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
335,000 |
335,000 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2020-12-22 |
4 |
AS |
$24.39 |
$9,335,716 |
D/D |
(364,451) |
898,215 |
|
-6% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-12-22 |
4 |
OE |
$3.01 |
$1,096,998 |
D/D |
364,451 |
1,262,666 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2020-12-21 |
4 |
AS |
$20.38 |
$7,718,327 |
D/D |
(335,549) |
898,215 |
|
18% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-12-21 |
4 |
OE |
$2.27 |
$965,877 |
D/D |
335,549 |
1,233,764 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-24 |
4 |
S |
$14.39 |
$21,462 |
I/I |
(1,492) |
0 |
|
-126% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-23 |
4 |
S |
$15.03 |
$3,785,614 |
I/I |
(251,837) |
1,492 |
|
-138% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-20 |
4 |
S |
$15.11 |
$2,233,538 |
I/I |
(147,799) |
253,329 |
|
-129% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-19 |
4 |
S |
$15.55 |
$34,226 |
I/I |
(2,201) |
401,128 |
|
-120% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-18 |
4 |
S |
$15.71 |
$603,004 |
I/I |
(38,381) |
403,329 |
|
-117% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-16 |
4 |
S |
$15.90 |
$675,347 |
I/I |
(42,488) |
441,710 |
|
-84% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-12 |
4 |
S |
$16.73 |
$3,345,800 |
I/I |
(200,000) |
484,198 |
|
-83% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-11 |
4 |
S |
$16.46 |
$4,116,000 |
I/I |
(250,000) |
684,198 |
|
-80% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-11 |
4 |
S |
$14.25 |
$2,788,041 |
D/D |
(195,652) |
898,215 |
|
-80% |
|
| Hunkapiller Michael |
Director |
– • – |
2020-11-10 |
4 |
S |
$14.25 |
$18,586,959 |
D/D |
(1,304,348) |
1,093,867 |
|
-123% |
|
| Kim Susan G. |
Chief Financial Officer |
• – – |
2020-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
|
- |
|
| Henry Christian O |
Chief Executive Officer |
• • – |
2020-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
750,000 |
750,000 |
|
- |
|
| Hunkapiller Michael |
CEO & President |
• • – |
2020-08-21 |
4 |
S |
$6.57 |
$1,246,915 |
I/I |
(189,847) |
1,421,994 |
|
-328% |
|
| Hunkapiller Michael |
CEO & President |
• • – |
2020-08-20 |
4 |
S |
$6.47 |
$1,659,802 |
I/I |
(256,554) |
1,611,841 |
|
-308% |
|
| Gong Benjamin B |
Interim CFO and PAOOfficer |
• – – |
2020-08-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
82,347 |
|
389% |
|
| Schaefer Eric |
VP Chief Accounting OfficerOff |
• – – |
2020-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,999 |
|
238% |
|
| Seipert Christopher J. |
VP, Sales, Service & SupportOf |
• – – |
2020-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
66,329 |
|
25% |
|
| Zaccarin Denis |
SVP, Research & DevelopmentOff |
• – – |
2020-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
81,281 |
|
25% |
|
239 Records found
|
|
Page 5 of 10 |
|
|
0.09 (6.52%) 
